Aristotle University Of Thessaloniki (AUTH)
Ποιότητα ζωής σε παιδιά με νευροϊνωμάτωση τύπου 1: Συσχέτιση με κλινικοεργαστηριακές παραμέτρους
Abstract
dc:descriptionNeurofibromatosis type 1 (NF1) is a multisystem genetic disorder which shows variable clinical expressivity and it is almost impossible to precisely predict its severity and clinical course. NF1 has a prevalence of 1:3000-3500 around the world, independently of ethnic or racial background. The responsible gene is located on chromosome 17q11.2 and it is considered to be a tumour suppressor gene. NF1 is an autosomal dominant condition and completely penetrant, although approximately half of the cases represent new mutations. Diagnosis of NF1 is made on the criteria set by the National Institutes of Health. Its main clinical manifestations include café-au-lait spots, neurofibromas (cutaneous, subcutaneous and plexiform), skinfold freckling, optic pathway gliomas, skeletal anomalies and Lisch nodules. Furthermore, there is an increased incidence of cognitive deficits among children with NF1, as well as a tendency to be shorter compared to their healthy siblings. The pathophysiology and the underlying pathogenetic mechanisms of NF1 are yet to be fully understood. The act of the NF1 gene as a tumour suppressor gene helps to interpret a lot of the patsy manifestations of the disease and the increased rate various neoplasms in the NF1 population. The gene product, neurofibromin, is a polypeptide which acts as a regulator of cellular growth and cellular function (of the astrocytes and of the Schwann cells in particular) through various intracellular mechanisms and its lack or reduced production seems to hold a key role in the appearance of patsy as well as diffuse manifestations of NF1. In the last two decades after the identification and cloning of the NF1 gene, clinical and laboratory research has provided a lot of new evidence for the disease. Nevertheless, despite the large number of publications which refer to NF1, literature concerning quality of life (QoL) in children with NF1, in very sparse. The aim of this study is to evaluate the QoL in children with NF1 and to highlight the disease parameters which bear the greater impact. For this purpose the Child Health Questionnaire - Parent Form 50 (CHQ) was used. CHQ is a generic instrument, translated in Greek and validated for use in Greek patients. It measures by means of 50 items (questions) the impact of the disease on 12 aspects of QoL, covering the entire spectrum of QoL (physical functioning, social-school life, emotional and psychological status), and provides two summary scores, one for the physical and one for the psychosocial well-being of the patientευεξία των ασθενών. The CHQ results of the NF1 group were compared to those of a group of healthy age-matched peers. Furthermore, the patients underwent a series of clinical and laboratory tests in order to bring out disease complications with the greater impact. Statistical analysis was performed be means of Pearson and non-parametric Spearman correlations. Statistical significance was set at p<0,05). Conclusions: The use of CHQ in a group of Greek pediatric patients with NF1 and the statistical analysis of its results along with the results from the clinical and laboratory research led to the following results: 1. NF1 causes a statistically significant adverse overall effect on the patients QoL when compared to their healthy peers, and thus the initial hypothesis, made during the design of the study, is confirmed. 2. Cognitive deficits, central nervous system lesions, neurological, ophthalmologic and neuroophthalmologic complications and changes of appearance due to the cutaneous manifestations of the disease have the greatest impact on QoL 3. Good family relations and strong family cohesion are factors leading to improvement of the patients QoL. 4. More studies with larger cohorts of patients are needed for in order to clearly distinguish the disease-related variables with the greater impact on QoL, but also to set therapeutic goals which will include QoL as an endpoint. The results of this study combined with the results of other available studies could be considered a basis for the future development of a NF1-specific QoL instrument.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vardarinos, Athanasios
- Βαρδαρινός, Αθανάσιος
Subjects
dc:subject × 15- Νευροϊνωμάτωση τύπου 1
- Ποιότητα ζωής
- Παιδιά
- Οπτικά γλοιώματα
- Μαθησιακές διαταραχές
- Neurofibromatosis type 1
- Quality of life (QOL)
- Children
- Optic pathway gliomas
- Learning difficulties
- Child kealth questionaire - parent form 50
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18714